Under obesogenic conditions, such as high-fat diet feeding, it is unclear whether ASGR1 can potentially reprogram hepatocyte metabolism and have a favorable effect on lipid profiles, thereby impacting the onset of metabolic syndrome and obesity. Here, ASGR1 is linked to metabolic syndrome.